Documents & Downloads

BRM/BRG1 ATP-IN-8

BRG1/BRM Inhibitor

BRM/BRG1 ATP-IN-8 is a selective inhibitor targeting the BRG1/BRM ATPase domain, demonstrating potent antitumor activity. By disrupting aberrant chromatin remodeling, this compound effectively induces apoptosis and growth arrest in cancer cells. BRM/BRG1 ATP-IN-8 is well-suited for research into BRG1/BRM-dependent malignancies, including hematological cancers, prostate cancer, breast cancer, and Ewing's sarcoma.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2468046-72-0
Applications	BRG1/BRM Inhibitor
Formula	C₂₆H₂₃N₅O₆S₂
Molecular Weight	565.62
SMILES	O=C(C1(CC1)C2=NC=CC(C3=CC=CC(C4=CSC(NC(CNC(C5=CN(S(=O)(C)=O)C=C5)=O)=O)=N4)=C3)=C2)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.